The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity

• Published in: Journal of pharmacy and pharmacology 2014-09, Vol.66 (9), p.1339-1346
• Main Authors: Mooiman, Kim D., Goey, Andrew K.L., Huijbregts, Tomy J., Maas-Bakker, Roel F., Beijnen, Jos H., Schellens, Jan H.M., Meijerman, Irma
• Format: Article
• Language: English
• Subjects: 7-benzyloxy-4-trifluoromethyl coumarin; Aryl Hydrocarbon Hydroxylases - metabolism; Camellia sinensis; complementary and alternative medicine; Complementary Therapies; Coumarins - metabolism; cytochrome P450 2C9; Herb-Drug Interactions; Humans; Microsomes, Liver - drug effects; Milk; pharmacokinetic interactions; Plant Extracts - pharmacology; Silybin; Silybum marianum - chemistry; Silymarin - pharmacology; tolbutamide; Tolbutamide - metabolism
• ISSN: 0022-3573; 2042-7158
• DOI: 10.1111/jphp.12259

Objectives The aim of this study is to establish the inhibitory effects of 14 commonly used complementary and alternative medicines (CAM) on the metabolism of cytochrome P450 2C9 (CYP2C9) substrates 7‐methoxy‐4‐trifluoromethyl coumarine (MFC) and tolbutamide. CYP2C9 is important for the metabolism of numerous drugs and inhibition of this enzyme by CAM could result in elevated plasma levels of drugs that are CYP2C9 substrates. Especially for anticancer drugs, which have a narrow therapeutic window, small changes in their plasma levels could easily result in clinically relevant toxicities. Methods The effects of CAM on CYP2C9‐mediated metabolism of MFC were assessed in Supersomes, using the fluorometric CYP2C9 inhibition assay. In human liver microsomes (HLM) the inhibition of CYP2C9‐mediated metabolism of tolbutamide was determined, using liquid chromatography coupled to tandem mass spectrometry (LC‐MS/MS). Key findings The results indicated milk thistle as the most potent CYP2C9 inhibitor. For milk thistle, silybin (main constituent of milk thistle) was mainly responsible for the inhibition of CY2C9. Conclusions Milk thistle and green tea were confirmed as potent inhibitors of CYP2C9‐mediated metabolism of multiple substrates in vitro. Clinical studies with milk thistle are recommended to establish the clinical relevance of the demonstrated CYP2C9 inhibition.